It is a synthetic fluoroquinolone antibiotic agent. We have been setting benchmarks of success in the market as a prominent organization, engaged in offering Moxifloxacin. To comply with set safety norms, we use finest quality compounds to process this drug. It is used for the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also, this drug is used for the treatment of bacterial conjunctivitis. The mode of action of Moxifloxacin depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.